Symptoms Sufficient to Prompt Infliximab-dose Increases in Crohn ' s Disease Symptoms Sufficient to Prompt Infliximab-dose Increases in Crohn ' s Disease

Symptoms alone are as useful as a combination of symptoms, biomarkers and serum drug concentrations for determining the need for an increased dose of infliximab in patients with Crohn ' s disease (CD), according to results from a randomized trial.Reuters Health Information
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Medscape Today News Source Type: news